BioHarvest Sciences (BHST) Corporate presentation summary

Leadership and team

• Executive team includes experienced leaders in biotech, pharma, finance, and business development.

• Co-founders and advisors have backgrounds in strategic growth and disruptive technologies.

Business model and strategy

• Operates as a plant cell culture company with a proprietary industrial biology platform.

• Dual value creation engines: direct-to-consumer (D2C) products and CDMO (contract development and manufacturing organization) partnerships.

• Focuses on nutraceutical, cosmetic, pharma, and nutrition sectors.

• Diversified pipeline across four industries, leveraging AI for discovery and scale-up.

Technology and platform

• Proprietary platform enables rapid, precise scaling of plant cell cultures from a single plant blueprint.

• Technology delivers scalable, predictable, and sustainable production with superior bioavailability and lower costs.

• AI-driven development enhances yield, consistency, and discovery pipeline.

• Patent-protected compositions and ultra-potent molecules not possible in nature.